SciELO - Scientific Electronic Library Online

 
vol.75 número6Hybrid Therapies for Supporting Critically Ill Patients with Acute Kidney Injury: When, how, and for Whom?Adsorptive Therapies in Sepsis and Inflammation: Description of the Various Adsorptive Techniques and their Failure to Improve Outcomes índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista de investigación clínica

versión On-line ISSN 2564-8896versión impresa ISSN 0034-8376

Resumen

GALINDO, Pablo  y  NEYRA, Javier A.. Continuous Renal Replacement Therapy: What Have We Learned And What Are Key Milestones For The Years To Come?. Rev. invest. clín. [online]. 2023, vol.75, n.6, pp.348-358.  Epub 12-Mar-2024. ISSN 2564-8896.  https://doi.org/10.24875/ric.23000221.

Continuous renal replacement therapy (CRRT) is the main extracorporeal kidney support therapy used in critical ill patients in the intensive care unit (ICU). Since its conceptualization ~50 years ago, there have been major improvements in its technology and utilization. The last decade, and particularly since the COVID-19 pandemic, has been marked by a growing interest and demand of CRRT in worldwide ICUs. This has underpinned the need for improvements in nomenclature and process standardization, optimization of CRRT deliverables, and the development and validation of key performance indicators. Further, how to leverage digital health technologies to build clinical decision support for CRRT and improve personalized bedside decisions is a subject of intense investigation. Herein, we summarize notable advancements in the provision of CRRT and propose areas in need of further development.

Palabras llave : Continuous renal replacement therapy; Technological advances; Therapy deliverables; Prescription standardization; Artificial intelligence; Challenges.

        · texto en Inglés     · Inglés ( pdf )